ExeVir Bio

Zwijnaarde, Belgium

ExeVir Bio is a Belgium-based company that develops single-domain antibody-based therapies that help patients ward off viral infections.

$1.7M raised

Jun 2023

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has ExeVir Bio raised?

ExeVir Bio has raised $1.7M in total funding. The most recent round was Grant. The last funding was announced in June 2023.

Who are ExeVir Bio's investors?

ExeVir Bio's investors include European Investment Bank, V-Bio Ventures, VIB, UCB Ventures, Vives Louvain Technology Fund.

Where is ExeVir Bio headquartered?

ExeVir Bio is headquartered in Zwijnaarde, Belgium.

What does ExeVir Bio do?

ExeVir Bio is a Belgium-based company that develops single-domain antibody-based therapies that help patients ward off viral infections.

What stage is ExeVir Bio at?

ExeVir Bio is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 28, 2023.

MLA

"ExeVir Bio — Funding & Investors." VCBacked, June 28, 2023, https://www.vcbacked.co/company/exevir-bio. Accessed July 1, 2026.

APA

VCBacked. (2023). ExeVir Bio — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/exevir-bio

Wikipedia (cite web)

{{cite web |title=ExeVir Bio — Funding & Investors |url=https://www.vcbacked.co/company/exevir-bio |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 28, 2023.